NEW YORK (Reuters) - Johnson & Johnson on Thursday said it aims to revamp a now-closed Pennsylvania plant that made Tylenol and other consumer medicines that have been recalled in recent months due to quality-control lapses, and eliminate 300 of the factory’s more than 400 employees.
